Form 4 for MET MetLife
Accepted 2026-02-26 00:00:00 ET · period of report 2026-02-24 · accession 0001770295-26-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-26 | 2026-02-24 | MET | DEBEL MARLENE | EVP, CRO | F - Tax | $75.34 | -5,624 | 158.5K | -3% | -$423.7K | |
| M | 2026-02-26 | 2026-02-24 | MET | DEBEL MARLENE | EVP, CRO | A - Grant | — | +30.0K | 164.1K | +22% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-24 | F | D | 5,624 | $75.34 | 158,513 | D | — | — | |
| 2 | Common | Common Stock | 2026-02-24 | A | A | 15,132 | — | 149,267 | D | — | — | (F1) Restricted stock unit award under the MetLife, Inc. 2025 Stock and Incentive Compensation Plan. |
| 3 | Common | Common Stock | 2026-02-24 | A | A | 14,870 | — | 164,137 | D | — | — | (F2) Shares acquired from the determination of the performance factor for and payout of 2023-2025 performance share award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. |